Cells of the Immune System
A single drop of human blood, roughly 5 microliters, contains about 25,000 white blood cells. No two types do the same job. Some hunt and eat bacteria within minutes of a wound. Others patrol the tissues for weeks, sampling the environment and reporting back to lymph nodes. Still others kill virus-infected cells outright, without ever having seen that virus before. Understanding what these cells are, where they come from, and what each one specifically does is the anatomical foundation for everything else in immunology. The question that motivates this article is deceptively simple. When a splinter breaks the skin and bacteria pour in, what actually happens? What happens in the first hour, the first day, and the first week? The answer is not "the immune system responds." It is a specific, ordered cast of cells arriving in sequence. Each has a distinct receptor repertoire, a distinct lifespan, and a distinct set of weapons. Neutrophils arrive first and die fast. Macrophages arrive and stay, cleaning up and remodeling tissue. Dendritic cells arrive, pick up antigen, and leave. They migrate to lymph nodes to start adaptive immunity. Natural killer cells patrol constantly, checking that every cell they meet still looks like "self." Lymphocytes — T and B cells — wait in secondary lymphoid organs. They wait for a signal that a specific threat has been found. This matters because nearly every disease of immune dysfunction is a disease of these specific cells. This includes chronic granulomatous disease, leukemia, sepsis, and the cytokine storms of severe infection. Each involves one or more of these cell types malfunctioning, missing, or overreacting. You cannot understand autoimmunity, vaccine design, cancer immunotherapy, or transplant rejection without first knowing which cell does what. This article builds that cast of characters. It covers their surface markers, their weapons, and their lifespans. It also covers the classic experiments that proved each cell does what we say it does. These include cell transfer studies, depletion experiments, and congenital immunodeficiency case studies. The article proceeds from the myeloid lineage (neutrophils, macrophages, dendritic cells) through the innate lymphoid lineage (NK cells) to the adaptive lymphocytes (T and B cells). It builds toward the hematopoietic tree. It also builds toward the mechanistic detail of phagocytosis and NK recognition that follow this foundation.
- White blood cells (leukocytes) split into myeloid (neutrophils, monocytes/macrophages, dendritic cells) and lymphoid (T cells, B cells, NK cells) lineages, all from one hematopoietic stem cell.
- Neutrophils are short-lived (6–8 hours in blood), the most numerous leukocyte (50–70%), and the first responders to bacterial infection, killing via phagocytosis, ROS, and NETs.
- Macrophages are long-lived tissue residents that phagocytose pathogens and debris, present antigen, and orchestrate repair and inflammation via cytokines.
- Dendritic cells are the essential bridge between innate and adaptive immunity: they capture antigen in tissue and migrate to lymph nodes to activate naive T cells.
- NK cells kill virus-infected and tumor cells without prior sensitization, using "missing-self" recognition rather than antigen-specific receptors.
- Lymphocytes (T and B cells) provide antigen-specific adaptive immunity and immunological memory, distinguishing them from all innate cells described here.
Every leukocyte descends from a common hematopoietic stem cell but diverges into specialists — fast-acting, short-lived innate phagocytes versus slow, antigen-specific, long-memory lymphocytes — and effective host defense depends on this division of labor working in the correct sequence.
The core idea
The immune system is not one cell type but a division of labor among many, all descended from a single progenitor: the hematopoietic stem cell (HSC) in bone marrow. From the HSC, two broad lineages diverge. The myeloid lineage produces granulocytes (neutrophils, eosinophils, basophils), monocytes (which become macrophages and some dendritic cells), and red blood cells and platelets. The lymphoid lineage produces T lymphocytes, B lymphocytes, and natural killer (NK) cells. This lineage split, worked out through decades of colony-forming assays and lineage-tracing studies, explains why cells that look completely different — a phagocytic neutrophil and an antigen-specific T cell — share a developmental origin but almost nothing else functionally. A second organizing distinction cuts across the myeloid/lymphoid split: innate versus adaptive. Neutrophils, macrophages, dendritic cells, and NK cells are innate — they recognize broad, conserved molecular patterns (via pattern recognition receptors like Toll-Like Receptors) rather than one specific antigen, they act within minutes to hours, and individual cells do not "remember" a prior encounter. T and B lymphocytes are adaptive — each cell bears one unique antigen receptor generated by V(D)J Recombination, they take days to mobilize on first encounter, but they generate long-lived memory cells that respond faster and stronger on re-exposure. Dendritic cells sit at the seam between these systems: innate in their recognition strategy, but functionally indispensable for launching the adaptive response. A third axis is kinetics and location. Neutrophils are blood-circulating, terminally differentiated, and suicide within hours to days at a site of infection. Macrophages and dendritic cells are tissue-resident or tissue-infiltrating, live for weeks to months (some tissue macrophages are seeded before birth and self-renew for a lifetime), and function as sentinels. NK cells continuously patrol blood and tissues. Lymphocytes recirculate between blood, lymph, and secondary lymphoid organs (lymph nodes, spleen), waiting in a resting state until their specific antigen appears. Grasping these three axes — lineage origin, recognition strategy, and residence/kinetics — is what allows a student to place any new immune cell correctly.
Mechanism — how each cell type actually works
Neutrophils (polymorphonuclear leukocytes, PMNs) are produced in bone marrow at a staggering rate — roughly 10^11 per day in an adult human — and make up 50–70% of circulating white blood cells (typical adult range 2,500–7,500 cells/μL). They are recognizable by a multilobed nucleus (3–5 lobes) and cytoplasmic granules containing myeloperoxidase, lysozyme, and defensins. Circulating half-life is only 6–8 hours; once they migrate into infected tissue they survive perhaps 1–2 days before undergoing apoptosis, leaving the debris that forms pus. Mechanistically, at a site of infection, resident macrophages and damaged tissue release chemokines (notably CXCL8/IL-8) and lipid mediators (leukotriene B4). Neutrophils in nearby blood vessels sense these signals and undergo a stepwise adhesion cascade: selectin-mediated rolling along the vessel wall, integrin (LFA-1, Mac-1) activation and firm adhesion, then transendothelial migration (diapedesis) into tissue, following the chemokine gradient (chemotaxis). Once at the site, neutrophils recognize pathogens via pattern recognition receptors and complement/antibody receptors, engulf them by phagocytosis, and kill them inside a phagosome using a respiratory burst (NADPH oxidase generating superoxide and downstream reactive oxygen species) plus granule enzymes. A distinct killing mode discovered more recently is the NET (neutrophil extracellular trap): the neutrophil expels a web of decondensed chromatin studded with antimicrobial proteins, physically trapping and killing extracellular bacteria, often at the cost of the neutrophil's own life (a process called NETosis).
Macrophages derive from circulating monocytes (or, in several tissues, from yolk-sac/fetal-liver precursors seeded before birth) and differentiate upon entering tissue into resident populations with tissue-specific names: Kupffer cells (liver), alveolar macrophages (lung), microglia (brain), osteoclasts (bone). Unlike neutrophils, macrophages are long-lived — weeks to years — and many self-renew locally without continuous replenishment from blood monocytes. Their central job is threefold: (1) phagocytose pathogens, dead cells, and debris, using scavenger receptors, complement receptors, and Fc receptors; (2) secrete cytokines (TNF-α, IL-1, IL-6, IL-12) that orchestrate local inflammation, fever, and recruitment of other leukocytes; (3) process ingested antigen and present peptide fragments on MHC class II to helper T cells, linking innate detection to adaptive activation. Macrophages also exhibit functional plasticity, often described (as a simplification of a continuous spectrum) as M1 (classically activated, pro-inflammatory, microbicidal, induced by IFN-γ and LPS) versus M2 (alternatively activated, pro-repair, induced by IL-4/IL-13) states — a framework useful for teaching but understood to be a spectrum rather than two discrete boxes.
Dendritic cells (DCs) are named for their long membrane processes, which dramatically increase surface area for antigen sampling. They exist in an "immature" state in peripheral tissues (skin, gut, lung), where they are highly phagocytic/endocytic but poor at activating T cells. Upon encountering pathogen-associated molecular patterns via pattern recognition receptors, an immature DC undergoes maturation: it upregulates MHC class I and II, upregulates costimulatory molecules CD80/CD86, downregulates antigen capture, and migrates via lymphatic vessels — following a CCR7-chemokine gradient — to the T cell zones of the draining lymph node. There, the mature DC presents processed peptide on MHC to circulating naive T cells. This is the only cell type efficient enough, and equipped with high enough costimulatory signal, to reliably activate a naive T cell that has never encountered antigen before — a role no other cell (including macrophages and B cells, which are also "professional" antigen-presenting cells but act mainly on already-activated T cells) fills as effectively for priming.
NK cells are large granular lymphocytes, lineage-related to T and B cells but part of innate immunity: they express no rearranged antigen-specific receptor. Instead, each NK cell carries a combinatorial array of activating and inhibitory receptors (in humans, largely killer-cell immunoglobulin-like receptors, KIRs, and the lectin-like receptor NKG2A) that read out the density of MHC class I on the surface of any cell it contacts. Healthy cells display abundant self MHC class I, which engages inhibitory receptors and delivers a dominant "don't kill" signal. Virus-infected cells and many tumor cells downregulate MHC class I (partly as an immune-evasion tactic against T cells) — this loss of inhibitory signal, combined with upregulated stress ligands engaging activating receptors, tips the balance toward killing. This is the missing-self hypothesis. Once triggered, NK cells kill by releasing perforin (which perforates the target membrane) and granzymes (proteases that enter through the perforin pores and trigger the target's own apoptosis machinery) — the same cytotoxic mechanism used by CD8+ cytotoxic T lymphocytes, but deployed without prior antigen-specific priming.
Lymphocytes — T and B cells — comprise about 20–40% of blood leukocytes and are morphologically similar (small, round, dense nucleus, thin rim of cytoplasm) but functionally distinct. B cells mature in bone marrow, express surface immunoglobulin (the B cell receptor) that recognizes native (unprocessed) antigen directly, and upon activation differentiate into antibody-secreting plasma cells. T cells mature in the thymus, express the T cell receptor (TCR), which recognizes only peptide fragments presented on MHC molecules — never free antigen — and split into CD4+ helper T cells (which coordinate other immune cells via cytokines and CD40L signaling) and CD8+ cytotoxic T cells (which kill infected or malignant cells via the perforin/granzyme pathway, echoing NK cell mechanics but triggered by specific antigen recognition on MHC class I). Because lymphocytes generate memory cells after activation, they are the cellular basis of vaccination and long-term immunity — a property innate cells largely lack, though "trained immunity" (epigenetic reprogramming of innate cells after infection) is an active area showing partial exceptions to this rule.
The evidence — the classic experiments that established these cell identities
Metchnikoff and the discovery of phagocytosis (1882–1908). Ilya Metchnikoff inserted a rose thorn into a translucent starfish larva and, watching under a microscope, saw mobile mesenchymal cells swarm and engulf the foreign material within hours — before any antibody-based explanation was conceivable. He extended this to observe leukocytes engulfing bacteria in vertebrates and proposed that phagocytic cells, not humoral factors, were the primary defense against infection. This was fiercely contested at the time by the "humoralist" school (championed by Paul Ehrlich), who argued that soluble blood factors (what we now call antibody and complement) were primary. The dispute was formally resolved in 1908, when Metchnikoff and Ehrlich shared the Nobel Prize in Physiology or Medicine — both were right, describing what are now the innate cellular and the innate/adaptive humoral arms of immunity respectively. Metchnikoff's work is the direct ancestor of everything we now know about neutrophil and macrophage function.
Steinman and the discovery of the dendritic cell (1973). Ralph Steinman and Zanvil Cohn, using electron microscopy and cell fractionation of mouse spleen, identified a rare, morphologically distinct cell type with long dendritic processes, distinguishable from macrophages by its weak phagocytic activity but potent capacity to stimulate lymphocyte proliferation in mixed lymphocyte reaction assays. Steinman showed that purified DCs, at very low numbers, were dramatically more potent than any other splenic cell population at triggering a primary T cell response — a finding initially met with skepticism because it implied a specialized cell existed solely to initiate adaptive immunity. Decades of follow-up work (DC depletion in transgenic mice using diphtheria toxin receptor systems, which abolished the ability to prime naive T cells against a model antigen) confirmed the causal, non-redundant role of DCs in initiating adaptive responses. Steinman received the Nobel Prize in Physiology or Medicine in 2011.
Discovery of NK cells and the missing-self hypothesis (Kiessling, Herberman 1975; Ljunggren & Kärre 1985–90). Rolf Kiessling and Ronald Herberman independently reported that mouse spleen cells, with no prior immunization, could lyse certain tumor cell lines in vitro — "natural" killing, unlike the antigen-specific cytotoxicity known from immunized T cells. This was surprising because it violated the assumption that cytotoxic lymphocytes required prior sensitization. The mechanistic explanation came a decade later from Klas Kärre and Hans-Gustaf Ljunggren, who showed that mutant tumor cell lines selected for low or absent MHC class I expression were killed far more efficiently by NK cells than their MHC-class-I-intact parental lines, while the same low-MHC cells were often less susceptible to cytotoxic T cells (which require MHC to recognize antigen at all). Restoring MHC class I expression to the low-expressing tumor cells (by transfection) protected them from NK lysis. This reciprocal relationship — T cells need MHC to kill, NK cells are unleashed by its absence — is the direct experimental foundation of the missing-self model.
Chronic granulomatous disease as a natural "knockout" experiment. Clinical observation of children with recurrent, severe bacterial and fungal infections (catalase-positive organisms particularly) led to the discovery that their neutrophils could phagocytose bacteria normally but could not kill them — the respiratory burst was absent or greatly reduced. This was later traced to inherited mutations in components of the NADPH oxidase complex (e.g., the gp91^phox subunit, encoded on the X chromosome, explaining X-linked inheritance in most cases). This human disease functions as a natural loss-of-function experiment, directly demonstrating that reactive oxygen species generation, not phagocytosis alone, is required for neutrophil-mediated killing of many pathogens.
Worked examples
Example 1 — Reading a complete blood count (CBC) differential. A patient presents with fever and a CBC differential shows: white blood cell count 18,000/μL (reference 4,500–11,000), with 85% neutrophils (reference 50–70%), 3% lymphocytes (reference 20–40%), 10% monocytes (reference 2–8%), and a report of "12% bands" (immature neutrophils, reference <5%). Reasoning through it: the absolute neutrophil count is 18,000 × 0.85 ≈ 15,300/μL, roughly 4–5 times normal. The marked neutrophilia plus a "left shift" (elevated immature bands being released early from marrow reserves because mature neutrophils are being consumed faster than normal turnover) is the classic signature of acute bacterial infection — bone marrow is compensating for neutrophils dying rapidly at a tissue site of infection, consistent with their known 6–8 hour circulating half-life and rapid consumption during phagocytic combat. The low relative lymphocyte percentage is not necessarily a true lymphopenia — it can be partly a mathematical artifact of the neutrophil surge dominating the differential's denominator (this is why absolute counts, not just percentages, matter clinically). This pattern would be atypical for a viral infection, which more classically produces a relative lymphocytosis rather than neutrophilia, illustrating how a differential count is itself a window onto which cell lineage is being mobilized.
Example 2 — Interpreting an NK-cell cytotoxicity assay. A researcher performs a classic ⁵¹Cr-release cytotoxicity assay (the historical gold-standard assay, conceptually equivalent to modern flow-cytometric killing assays) using purified NK cells against three target cell lines:
| Target cell line | MHC class I expression | % specific lysis by NK cells |
|---|---|---|
| Line A (parental) | Normal/high | 8% |
| Line B (MHC-I knockdown) | Very low | 62% |
| Line C (MHC-I knockdown + MHC-I transgene re-expressed) | Restored | 11% |
Reasoning: Line A shows low lysis because normal MHC class I engages inhibitory KIR/NKG2A receptors, suppressing NK activation — the expected "self" signal. Line B, with MHC class I knocked down, shows a roughly 7- to 8-fold increase in lysis: removing the inhibitory ligand unmasks activating signals (from stress ligands like MICA/MICB engaging NKG2D) that were present all along but previously overridden. Line C confirms the causal role of MHC class I specifically (not some side effect of the knockdown procedure): restoring MHC class I expression on the same genetic background restores protection to near-baseline levels. This three-way comparison (parental, knockdown, rescue) is the standard experimental logic — the same logic Kärre and Ljunggren used — for proving that a specific molecule, not a general cellular difference, is responsible for an observed phenotype.
Common misconceptions & traps
| Misconception | Correction |
|---|---|
| "Macrophages and monocytes are the same cell." | Monocytes are the circulating precursor; macrophages are the differentiated, tissue-resident form. Many tissue macrophages are also seeded prenatally and self-renew independent of monocytes. |
| "NK cells are a type of T cell." | NK cells are lymphocytes but lack a rearranged antigen receptor and are part of innate immunity; T cells are adaptive and require the thymus and TCR rearrangement. |
| "Dendritic cells are just very active macrophages." | DCs are a distinct lineage specialized for antigen presentation and lymph-node migration, not simply "professional phagocytes" — mature DCs are actually poor phagocytes compared to immature DCs or macrophages. |
| "Neutrophils and lymphocytes work on the same timescale." | Neutrophils act within minutes to hours and die within a day or two; naive lymphocyte activation and clonal expansion takes several days, which is why adaptive immunity is inherently slower on a first encounter. |
| "More MHC class I on a cell always means more T-cell killing and more NK-cell killing." | The opposite is true for NK cells: high MHC class I inhibits NK killing (self signal), while it is required for CD8+ T cell recognition of antigen. The two innate/adaptive killer cells read MHC class I oppositely. |
The scientist behind it
Origins · 1 minIlya Ilyich Metchnikoff and how this was discovered
Metchnikoff was a Russian zoologist trained in comparative embryology, not medicine, which is precisely why he saw something clinicians had missed. Working with transparent marine larvae in Messina, Italy, he could watch, in real time, mobile cells engulfing foreign particles — an observation impossible in opaque mammalian tissue. He insisted, against the dominant humoral theory of the era, that cellular engulfment was itself a form of immune defense rather than mere waste disposal, a claim that took decades and mounting cross-species evidence to win over the field. He eventually joined the Pasteur Institute in Paris, where his phagocyte theory was tested against, and ultimately reconciled with, Ehrlich's antibody-based humoral theory. His insistence on direct microscopic observation over theoretical inference is a methodological lesson as important as the discovery itself.
Where this matters today
Neutropenia and infection risk. Chemotherapy and some leukemias suppress bone marrow output of neutrophils; when the absolute neutrophil count drops below about 500/μL, patients face life-threatening bacterial and fungal infection risk within days, directly reflecting how fast neutrophils normally turn over and how essential they are as first responders. Granulocyte colony-stimulating factor (G-CSF) is given clinically to accelerate neutrophil production from marrow precursors.
Dendritic cell vaccines in cancer immunotherapy. Because DCs are uniquely potent primers of naive T cells, therapies such as sipuleucel-T (for prostate cancer) load a patient's own DCs with tumor antigen ex vivo before reinfusion, aiming to trigger a tumor-specific cytotoxic T cell response — a direct clinical application of Steinman's basic discovery.
Macrophage-targeted anti-inflammatory drugs. Biologics that block macrophage-derived cytokines (anti-TNF-α agents such as infliximab, used in rheumatoid arthritis and inflammatory bowel disease) exploit precise knowledge of which cytokines macrophages release and why, to dampen chronic inflammatory disease without ablating the entire immune system.
NK cell-based cancer immunotherapy. Because tumors frequently downregulate MHC class I to escape CD8+ T cells, they paradoxically become more vulnerable to NK cells — this trade-off is now exploited therapeutically with engineered and adoptively transferred NK cells, and with antibodies (checkpoint-like reagents) that block inhibitory NK receptors to unleash tumor killing.
Chronic granulomatous disease management and gene therapy. Understanding the precise NADPH oxidase defect in neutrophils has enabled prophylactic antibiotic/antifungal regimens, interferon-gamma therapy, and experimental gene therapy correcting the defective gene in hematopoietic stem cells — connecting basic phagocyte biology directly to a treatable genetic disease.
Sepsis and cytokine storm. Excessive, dysregulated activation of macrophages and neutrophils (rather than pathogen load per se) is now recognized as a major driver of mortality in sepsis and in severe viral infections, motivating drugs that modulate innate cell cytokine output rather than only targeting the pathogen.
Ask the tutor: How exactly does a dendritic cell "decide" which naive T cells to activate once it reaches the lymph node, and why does costimulation (not just antigen recognition) determine whether that T cell is activated or rendered anergic?
Why do neutrophils die so quickly compared to macrophages?
Neutrophils are terminally differentiated cells built for a short, intense burst of activity rather than longevity. They are pre-loaded with granules and a functional NADPH oxidase at the time they leave the bone marrow, so they need no further maturation to fight — but this comes at a metabolic and structural cost, and they undergo constitutive apoptosis on a timescale of hours even without infection. At an infection site, the respiratory burst and degranulation used to kill pathogens also damage the neutrophil's own membranes and organelles, accelerating death; dying neutrophils and debris form what we recognize clinically as pus. Macrophages, by contrast, are built for sustained tissue residence, have more antioxidant defense, are less reliant on a one-time destructive burst, and in several tissues self-renew locally, giving them a lifespan of weeks to years rather than hours.
Are dendritic cells the only cells that can present antigen to T cells?
No, but they are the only cells efficient enough to reliably prime a naive T cell — one that has never encountered its antigen. Macrophages and B cells are also "professional" antigen-presenting cells (they express MHC class II and costimulatory molecules), but they mainly present antigen to T cells that are already activated or memory cells, sustaining or redirecting a response rather than initiating one. In principle, almost any nucleated cell can present endogenous peptide on MHC class I to CD8+ T cells, which is how virus-infected cells of any type get recognized and killed — but this is passive presentation of what the cell already contains, not the active antigen capture, processing, and migratory relay that defines dendritic cell function.
How does missing-self recognition differ from the pattern recognition used by macrophages and neutrophils?
Pattern recognition (used by neutrophils, macrophages, and dendritic cells) detects the presence of a foreign molecular signature — a bacterial cell wall component, viral RNA, or fungal cell wall sugar — via receptors like Toll-like receptors that bind conserved microbial structures directly. Missing-self recognition, used by NK cells, works by the opposite logic: it detects the absence of a normal self-marker (MHC class I) rather than the presence of anything foreign. This lets NK cells catch threats that evade pattern recognition entirely, such as virus-infected or tumor cells that have specifically downregulated MHC class I to escape T cell recognition — a strategy that backfires because it makes them targets for NK cells instead.
Why does a viral infection typically show a different white blood cell pattern than a bacterial infection?
Bacterial infections classically drive marrow to release large numbers of neutrophils quickly (neutrophilia, sometimes with immature "bands," a left shift) because neutrophils are the primary early responders against extracellular bacteria and are consumed rapidly. Viral infections more often provoke a relative or absolute lymphocytosis, reflecting proliferation and recruitment of T and NK cells responding to intracellular pathogens, along with type I interferon signaling that is less potent a neutrophil chemoattractant than bacterial products. This is a useful clinical heuristic, though it is a generalization: some bacteria (e.g., intracellular pathogens like Mycobacterium tuberculosis) and some viruses (e.g., certain hemorrhagic fever viruses) can produce atypical patterns.
What does it mean that macrophages show "M1/M2" polarization, and is this fully accurate?
M1 ("classically activated") macrophages are induced by signals like interferon-gamma and bacterial LPS, and are pro-inflammatory and strongly microbicidal, producing reactive oxygen species and pro-inflammatory cytokines. M2 ("alternatively activated") macrophages are induced by cytokines like IL-4 and IL-13, and favor tissue repair, wound healing, and resolution of inflammation. This binary framework is pedagogically useful but is now understood as a simplification: in vivo, macrophage activation states form a continuous spectrum shaped by the local tissue environment, and macrophages can display mixed or intermediate phenotypes rather than falling cleanly into one category.
Why are neutrophil counts, not just white blood cell totals, so important clinically?
The total white blood cell count is a sum across very different cell types with very different jobs, so it can mask what is actually happening immunologically. A patient could have a "normal" total WBC count while having severe neutropenia masked by lymphocytosis, or vice versa. Clinicians calculate the absolute neutrophil count (total WBC × percent neutrophils) specifically because neutrophil number predicts risk of acute bacterial and fungal infection far better than the total count does — a patient with an absolute neutrophil count below roughly 500/μL is considered severely neutropenic and at high infection risk, regardless of what the total white count says.
How does the article's cell cast connect to hematopoiesis and phagocytosis mechanism topics?
This article establishes identity and function — which cell is which, and broadly what it does — as the necessary scaffold before diving into mechanism in depth. Hematopoiesis: Origin of Immune Cells explains the developmental and molecular steps by which the hematopoietic stem cell commits to each lineage described here, including the transcription factors and cytokine signals that drive each branch point. Phagocytosis: Mechanism and Killing zooms into the neutrophil and macrophage sections above, detailing phagosome maturation, the respiratory burst, and granule fusion at the molecular level. Natural Killer Cells and Missing-Self Recognition expands the NK cell section here into the specific receptor biology (KIR gene families, NKG2D ligands, licensing) behind the missing-self logic introduced above.